收藏切换
Advances of clinical research on alternative therapy for hemophilia A, coagulation factor Ⅷ
收藏切换
Zhilong LAN1, Chunyu CHEN2, Dandan ZHAO2, Meng ZHANG2, Junlong WANG1, *, Na NI1, *
World Clinical Drug | 2024, 45(4) : 368 - 371
Less
收藏切换
World Clinical Drug | 2024, 45(4): 368-371
• Topic •
Advances of clinical research on alternative therapy for hemophilia A, coagulation factor Ⅷ
Full
Zhilong LAN1, Chunyu CHEN2, Dandan ZHAO2, Meng ZHANG2, Junlong WANG1, *, Na NI1, *
Affiliations
  • 1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China
Published: 2024-04-10 doi: 10.13683/j.wph.2024.04.004
Outline
收藏切换

Hemophilia A (HA) is a rare X-chromosome linked recessive hemorrhagic disorder caused by the deficiency or dysfunction of coagulation factor Ⅷ (FⅧ) in the blood. The incidence of HA is low, the cost of treatment is high, and there is no effective radical treatment at present. On-demand alternative treatment is still the most effective way to treat HA in our country. However, HA patients need lifelong medication, the existing drugs have short half-life, high injection frequency, easy to produce coagulation FⅧ inhibitors, and poor quality of life of patients. In view of such unmet clinical needs, this paper mainly reviewed the clinical research progress of three alternative therapeutic drugs: plasma-derived human coagulation FⅧ, recombinant human coagulation FⅧ and long-acting recombinant human coagulation FⅧFc fusion protein, to provide new ideas and basis for later drug development and clinical treatment.

hemophilia A  /  replacement therapy  /  plasma-derived human coagulation factor Ⅷ  /  recombinant human coagulation factor Ⅷ  /  reombint human coagulation factor Ⅷ-Fc fusion protein
兰志龙, 陈春宇, 赵丹丹, 张梦, 王俊龙, 倪娜. A型血友病替代治疗药物凝血因子Ⅷ的临床研究进展. 世界临床药物, 2024 , 45 (4) : 368 -371 . DOI: 10.13683/j.wph.2024.04.004
Zhilong LAN, Chunyu CHEN, Dandan ZHAO, Meng ZHANG, Junlong WANG, Na NI. Advances of clinical research on alternative therapy for hemophilia A, coagulation factor Ⅷ[J]. World Clinical Drug, 2024 , 45 (4) : 368 -371 . DOI: 10.13683/j.wph.2024.04.004
Year 2024 volume 45 Issue 4
22
6
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.04.004
  • Receive Date:2024-01-09
  • Online Date:2026-11-17
  • Published:2024-04-10
Article Data
Affiliations
History
  • Received:2024-01-09
Affiliations
    1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
    2.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.04.004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT